Caredx Inc [CDNA] stock is trading at $19.52, up 4.05%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CDNA shares have gain 14.89% over the last week, with a monthly amount glided 32.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on January 15, 2025, when Wells Fargo upgraded its rating to a Equal Weight and also revised its price target to $24 from $28. Previously, Wells Fargo started tracking the stock with Underweight rating on August 28, 2024, and set its price target to $28. On August 19, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $40 on the stock. Raymond James downgraded its rating to a Mkt Perform. Craig Hallum upgraded its rating to a Buy but $15 remained the price target by the analyst firm on May 01, 2024. Stephens upgraded its rating to Overweight for this stock on November 09, 2023, but kept the price target unchanged to $10. In a note dated August 15, 2023, Raymond James upgraded an Outperform rating on this stock but restated the target price of $12.
Caredx Inc [CDNA] stock has fluctuated between $13.18 and $34.84 over the past year. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $19.52 at the most recent close of the market. An investor can expect a potential return of 28.07% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Caredx Inc [NASDAQ:CDNA] reported sales of 346.42M for the trailing twelve months, which represents a growth of 17.54%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.18 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.20 points at the first support level, and at 18.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.68, and for the 2nd resistance point, it is at 19.85.
Ratios To Look Out For
For context, Caredx Inc’s Current Ratio is 4.11. As well, the Quick Ratio is 3.84, while the Cash Ratio is 1.04. Considering the valuation of this stock, the price to sales ratio is 3.14, the price to book ratio is 2.85 and price to earnings (TTM) ratio is 16.94.
Transactions by insiders
Recent insider trading involved HAGSTROM WILLIAM A, Director, that happened on May 28 ’25 when 30000.0 shares were sold. Director, HAGSTROM WILLIAM A completed a deal on May 28 ’25 to buy 30000.0 shares. Meanwhile, Director COURNOYER CHRISTINE sold 29136.0 shares on May 12 ’25.
